Abstract:Background Individuals with CKD may be at high risk for atherosclerotic cardiovascular disease (ASCVD). However, there are no ASCVD risk prediction models developed in CKD populations to inform clinical care and prevention. Methods We developed and validated 10-year ASCVD risk prediction models in patients with CKD that included participants without self-reported cardiovascular disease from the Chronic Renal Insufficiency Cohort (CRIC) study. ASCVD was defined as the first occurrence of adjudicated fatal and nonfatal stroke or myocardial infarction. Our models used clinically available variables and novel biomarkers. Model performance was evaluated based on discrimination, calibration, and net reclassification improvement. Results Of 2604 participants (mean age 55.8 years; 52.0% male) included in the analyses, 252 had incident ASCVD within 10 years of baseline. Compared with the American College of Cardiology/American Heart Association pooled cohort equations (area under the receiver operating characteristic curve [AUC]=0.730), a model with coefficients estimated within the CRIC sample had higher discrimination ( P =0.03), achieving an AUC of 0.736 (95% confidence interval [CI], 0.649 to 0.826). The CRIC model developed using clinically available variables had an AUC of 0.760 (95% CI, 0.678 to 0.851). The CRIC biomarker-enriched model had an AUC of 0.771 (95% CI, 0.674 to 0.853), which was significantly higher than the clinical model ( P =0.001). Both the clinical and biomarker-enriched models were well-calibrated and improved reclassification of nonevents compared with the pooled cohort equations (6.6%; 95% CI, 3.7% to 9.6% and 10.0%; 95% CI, 6.8% to 13.3%, respectively). Conclusions The 10-year ASCVD risk prediction models developed in patients with CKD, including novel kidney and cardiac biomarkers, performed better than equations developed for the general population using only traditional risk factors. Significance Statement Patients with CKD are typically considered to be at high risk for atherosclerotic cardiovascular disease, but CKD is a heterogeneous condition and there are no validated atherosclerotic cardiovascular disease risk stratification tools for this population. Our analysis of 2604 participants in the Chronic Renal Insufficiency Cohort study found that newly developed risk prediction models, using clinically available variables and novel biomarkers, improved discrimination, calibration, and reclassification of nonevents compared with the traditional American College of Cardiology/American Heart Association pooled cohort equations developed for the general population. The new equations may improve risk stratification in patients with CKD and improve shared decision making for preventive therapy to reduce atherosclerotic cardiovascular disease incidence and mortality. Visual

Integrating the patient voice: patient-centred and equitable clinical risk prediction for kidney health and disease

Risk models to predict chronic kidney disease and its progression: a systematic review

Prediction models for earlier stages of chronic kidney disease

The Role of Patient-Reported Experience and Outcome Measures in Kidney Health Equity-Oriented Quality Improvement

Computational and Human Intelligence Methods for Constructing Practical Risk Prediction Models: An Application to Cardio-Renal Outcomes in Non-Diabetic CKD Patients

Factors influencing clinician and patient interaction with machine learning-based risk prediction models: a systematic review

Promising algorithms to perilous applications: a systematic review of risk stratification tools for predicting healthcare utilisation

Patients' and Physicians' Beliefs and Attitudes towards Integrating Personalized Risk Estimates into Patient Education about Left Ventricular Assist Device Therapy

Role of personalized predictions for people with prediabetes: disseminating patient-centered estimates of benefit

Prognosis and Personalized In Silico Prediction of Treatment Efficacy in Cardiovascular and Chronic Kidney Disease: A Proof-of-Concept Study

Practicing health equity in kidney care by establishing improved access to timely disease management and kidney replacement therapy options: from providers to patients

Using prediction models to improve care and communicate risk: updated modeling for children with IgA nephropathy

When impact trials are not feasible: alternatives to study the impact of prediction models on clinical practice

Patients' and Clinicians' Perceptions of the Clinical Utility of Predictive Risk Models for Chemotherapy-Related Symptom Management: Qualitative Exploration Using Focus Groups and Interviews

[Progress in research of risk prediction model for chronic kidney disease].

Integration of Patient Reported Quality-of-life Data into Risk Assessment in Heart Failure

Artificial intelligence in chronic kidney diseases: methodology and potential applications

Computational Models Used to Predict Cardiovascular Complications in Chronic Kidney Disease Patients: A Systematic Review

Patient-Reported Outcomes to Achieve Person-Centered Care for Aging People With Kidney Disease

Risk Prediction Models for Atherosclerotic Cardiovascular Disease in Patients with Chronic Kidney Disease: The CRIC Study

Prediction of incident chronic kidney disease in community-based electronic health records: a systematic review and meta-analysis